ARCHIVES

FDA To Expand Disclosure For Advisory Committee Members

This article is from The Cancer Letter archive.

Vol. 36 No. 15 | April 23, 2010

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

January 20, 2006

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995

In Congress: Senate Passes Bill For DOD Medical Research Funding

August 14, 1998

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

Morale, Money Woes Hit MD Anderson

January 18, 2013

L-PAM, Less Than Radical Surgery Results Holding Up, New Breast Cancer Studies Sought

September 12, 1975